ICICI Direct has recommended a BUY rating on Narayana Hrudayalaya (NARHRU), a leading chain of multi-specialty hospitals, with a target price of Rs 1,485, representing a potential upside of 22% fro
Fortis Healthcare Ltd has announced that its board has approved the issuance of non-convertible debentures (NCDs) worth Rs 1,500 crore via private placement.
Chola Securities has issued a BUY recommendation for Narayana Hrudayalaya Limited (NHL), a leading healthcare provider, known for its expertise in cardiac, oncology, and nephrology treatments.
Biognosys, a frontrunner in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a pioneer in precision proteomics for early disease detection, have forged a strategic alliance to prop